U.S. Logistics Stock News

NasdaqGS:PICS
NasdaqGS:PICSDiversified Financial

Assessing PicS (PICS) Valuation After Recent Share Price Swings

PicS stock moves after recent performance shifts PicS (PICS) has drawn fresh attention after recent trading saw a 3.8% one day decline and an 8.7% gain over the past week, compared with weaker performance over the past month and year to date. See our latest analysis for PicS. With the share price at $17.08, PicS has seen a 3.8% one day share price return decline, a strong 7 day rebound, yet softer 30 day and year to date share price returns. This suggests that momentum has cooled after a...
NasdaqGS:GEN
NasdaqGS:GENSoftware

Is Gen Digital (GEN) Pricing Look Attractive After Recent Share Price Weakness?

If you are wondering whether Gen Digital is attractively priced right now, you are not alone. This article is aimed squarely at helping you make sense of the current valuation. The stock closed at US$22.57, with returns of 1.0% over the last 7 days, a 5.9% decline over 30 days, a 13.4% decline year to date, a 15.9% decline over 1 year, and gains of 24.8% over 3 years and 24.0% over 5 years. Taken together, these figures raise questions about how the market is currently judging it. Recent...
NYSE:ULS
NYSE:ULSProfessional Services

UL Solutions Raises Dividend While Pursuing Digital And Energy Transition Growth

UL Solutions (NYSE:ULS) announced an 11.5% increase to its quarterly dividend. Management highlighted digitalization, energy transition, and sustainability as key areas connected to recent growth efforts. Executives discussed progress in laboratory expansion, software integration, and restructuring initiatives. UL Solutions operates in testing, inspection, certification, and related software, serving companies that need to meet safety, quality, and regulatory standards. As more products,...
NYSE:TNK
NYSE:TNKOil and Gas

Is Teekay Tankers (TNK) Pricing Reflect Its Strong 1-Year Share Price Surge

If you are wondering whether Teekay Tankers is still good value after a strong run, this article walks through what the current price might be implying about the stock. The share price recently closed at US$78.27, with returns of 7.4% over 7 days, 21.3% over 30 days, 52.0% year to date and 116.6% over 1 year. Recent news coverage has focused on Teekay Tankers as a way to get exposure to tanker shipping, with attention on how freight rate conditions and fleet deployment decisions could affect...
NYSE:REXR
NYSE:REXRIndustrial REITs

Will Rexford's (REXR) Executive Pay Cut and COO Promotion Mark a New Capital Discipline Era?

Rexford Industrial Realty, Inc. recently promoted Managing Director of Operations John Nahas to Chief Operating Officer, effective April 1, 2026, completing an executive reshuffle alongside incoming CEO Laura Clark and reaffirming tighter expense guidance and lower aggregate executive compensation. The combination of a refreshed leadership team, a roughly 50% cut in total executive pay, and ongoing cost controls highlights a sharper emphasis on operational discipline and capital...
NYSE:ESAB
NYSE:ESABMachinery

Assessing ESAB (ESAB) Valuation After Mixed Short Term Share Price Performance

ESAB stock overview after recent performance shift ESAB (ESAB) has experienced a mixed run recently, with a modest 1 day gain, a 7 day decline, and positive moves over the past month and past 3 months. This performance has prompted investors to reassess its current setup. See our latest analysis for ESAB. At a share price of $126.17, ESAB has seen a 12.1% year to date share price return and a 109.9% total shareholder return over three years, which suggests longer term holders have been...
NYSE:ESNT
NYSE:ESNTDiversified Financial

A Look At Essent Group (ESNT) Valuation After Recent Share Price Weakness

Essent Group (ESNT) shares recently closed at $60.84, while returns over the past month and past 3 months have been slightly negative. This performance has kept the mortgage insurance specialist on many investors’ watchlists. See our latest analysis for Essent Group. Short term momentum for Essent Group has cooled, with a 1 month share price return of 3.31% decline and a year to date share price return of 5.92% decline, even as the 1 year total shareholder return of 7.83% and 5 year total...
NasdaqGS:ACIW
NasdaqGS:ACIWSoftware

ACI Worldwide’s UK Connetic Win Puts Cloud Payments Story To Test

ACI Worldwide secured the first UK deployment of its Connetic cloud-native payments platform with a major UK retail bank. The rollout brings multiple UK payment schemes onto a single platform, targeting greater efficiency and modernization for the bank. This marks a key step in ACI Worldwide’s push into European digital payments with its next-generation Connetic offering. For investors tracking ACI Worldwide, ticker NasdaqGS:ACIW, the Connetic win in the UK lands at a time when the stock...
NasdaqGS:SDGR
NasdaqGS:SDGRHealthcare Services

Schrödinger (SDGR) Valuation After 2025 Results And Shift To Hosted Licensing Model

Schrödinger (SDGR) has drawn fresh attention after reporting 2025 results, with total revenue of US$255.87 million, sales of US$56.37 million, and a net loss of US$103.27 million, along with operational changes. See our latest analysis for Schrödinger. The earnings update and shift toward hosted, throughput based licensing arrived after a tough stretch for shareholders, with a 90 day share price return decline of 29.23% and a 1 year total shareholder return decline of 45.94%, suggesting...
NYSE:AXS
NYSE:AXSInsurance

Is AXIS Capital’s Expanded Buyback and Dividends Altering The Investment Case For AXIS Capital Holdings (AXS)?

AXIS Capital Holdings recently declared a quarterly US$0.44 common dividend and a US$34.375 Series E preferred dividend per share, both payable on April 15, 2026 to shareholders of record on March 31, 2026, while also authorizing an additional US$300,000,000 share repurchase program. Together with a board retirement, these capital return moves underline how AXIS is currently prioritizing shareholder distributions alongside its ongoing specialty insurance focus. We’ll now examine how the...
NYSE:MET
NYSE:METInsurance

Is MetLife (MET) Quietly Redesigning Its Risk Profile With New Directors And 2056 Debt?

In late February 2026, MetLife, Inc. expanded its governance and capital structure by adding veteran executives Dan Glaser and Michelle Seitz to its board and completing a US$1.00 billion fixed-to-floating subordinated debenture offering due 2056, while also declaring dividends across multiple preferred stock series. Together, these board appointments and long-dated debt issuance highlight MetLife’s emphasis on experienced oversight and diversified funding as it balances business growth with...
NYSE:MATX
NYSE:MATXShipping

A Look At Matson’s Valuation As Earnings Beat And 2026 Guidance Signal Steady Operating Income

Why Matson’s latest earnings and guidance matter now Matson (MATX) has drawn fresh attention after fourth quarter 2025 earnings beat expectations while revenue softened, paired with 2026 guidance that points to a softer first quarter but full year operating income near 2025 levels. See our latest analysis for Matson. At a share price of $166.13, Matson’s recent move has cooled a little after its earnings release, with a 1 day share price return of a 1.44% decline and a 7 day share price...
NYSE:CWT
NYSE:CWTWater Utilities

Is California Water Service Group (CWT) Pricing Reflecting Its Dividend And Earnings Outlook?

If you are wondering whether California Water Service Group is fairly priced or offering value at around US$45.08, this article is for you if you want a clear view of what you might be paying for. The stock has had mixed returns, with a 1.5% decline over the last 7 days, a 1.4% gain over 30 days, 5.0% year to date, and 1.9% over 1 year. The 3 year and 5 year returns of 14.8% and 5.5% declines hint at a more complex long term story. Recent coverage of California Water Service Group has...
NasdaqGS:ALHC
NasdaqGS:ALHCHealthcare

Alignment Healthcare’s 2025 Beat And 2026 Outlook Refine Margin Story

Alignment Healthcare (NasdaqGS:ALHC) reported Q4 and full year 2025 results with revenue and health plan membership that outpaced its own guidance. The company exceeded its profitability goals for the year and raised its outlook for 2026. Alignment Healthcare was named to the 2026 Fortune World's Most Admired Companies list, highlighting its reputation in senior healthcare. Alignment Healthcare enters 2026 with fresh momentum after reporting stronger than guided revenue and membership...
NYSE:SWK
NYSE:SWKMachinery

Stanley Black & Decker (SWK) Is Down 5.9% After Closing Historic New Britain Plant - What's Changed

In late February 2026, Stanley Black & Decker announced it would close its last New Britain, Connecticut manufacturing plant, ending more than 180 years of local production and affecting about 300 workers as demand for single-sided tape measures structurally declines. At the same time, the Board reaffirmed a regular cash dividend of US$0.83 per share, underscoring management’s commitment to ongoing capital returns even as it reshapes its manufacturing footprint. Next, we’ll examine how...
NYSE:HRI
NYSE:HRITrade Distributors

Herc Holdings’ Record Acquisition Puts Integration Progress And Valuation In Focus

Herc Holdings (NYSE:HRI) has completed its largest acquisition to date, expanding its equipment rental footprint across local markets. The company is now concentrating on post-merger integration, including combining operations, systems, and teams across the enlarged network. Management is prioritizing cost synergies, higher used equipment sales, and branch network changes following the closing of the deal. Herc Holdings runs a broad equipment rental business that serves construction,...
NYSE:PMT
NYSE:PMTMortgage REITs

Will Strong Q4 Results and US$2.8 Billion Securitizations Change PennyMac Mortgage Investment Trust's (PMT) Narrative?

PennyMac Mortgage Investment Trust recently reported fourth quarter results, posting earnings per share of US$0.48, an annualized return on common equity of 13%, eight private label securitizations totaling US$2.80 billion, more than US$180 million of retained subordinate bond investments, and issued US$150 million of exchangeable senior notes to bolster liquidity. This combination of earnings strength, expanded securitization activity, and fresh exchangeable debt financing highlights how...
NYSE:GLP
NYSE:GLPOil and Gas

Global Partners’ Terminal Push and Higher Payouts Might Change The Case For Investing In GLP

Global Partners LP has reported past fourth-quarter 2025 results with sales of US$4,647.88 million and net income of US$20.13 million, alongside full-year sales of US$18,561.42 million and net income of US$79.22 million, reflecting higher quarterly revenue but lower annual earnings versus the prior year. Beyond the headline numbers, the period highlighted stronger Wholesale segment margins, the Providence terminal acquisition, expansion into the Houston bunkering market, and the seventeenth...
NasdaqGM:SUPN
NasdaqGM:SUPNPharmaceuticals

Supernus Pharmaceuticals (SUPN) Is Up 7.6% After Record Sales But 2025 Net Loss And Cautious 2026 Outlook

In February 2026, Supernus Pharmaceuticals reported fourth-quarter 2025 revenue of US$211.57 million and record full-year 2025 revenue of US$718.95 million, but swung to a full-year net loss of US$38.55 million and guided 2026 operating earnings to a range of US$0–US$30 million on expected total revenues of US$840–US$870 million. The results highlighted strong contributions from newer CNS products such as Qelbree, GOCOVRI, ZURZUVAE, and newly approved ONAPGO, alongside the completed Sage...
NasdaqGS:POOL
NasdaqGS:POOLRetail Distributors

Pool Highlights Resilience As Growth Shifts To Maintenance And Buybacks

Pool Corporation (NasdaqGS:POOL) is highlighting its resilience in a tough pool industry backdrop, with flat revenues and weakness in new pool construction. The company is leaning on pricing discipline, supply chain initiatives, and digital efforts to support gross margins and customer service. Ongoing acquisition activity remains part of Pool's growth playbook as it looks to expand its reach and capabilities. Pool, a major distributor of swimming pool supplies, equipment, and related...
NasdaqCM:THRY
NasdaqCM:THRYMedia

Is Thryv (THRY) Quietly Rewriting Its Story With ESOP Shares And Improving SaaS Margins?

In late February 2026, Thryv Holdings filed an US$8.15 million shelf registration for 2,179,185 common shares tied to its ESOP and reported fourth-quarter 2025 results showing quarterly sales of US$191.62 million, a net loss of US$9.66 million, and full-year 2025 sales of US$785.02 million with net income of US$0.31 million. Beyond the headline figures, the results underscored Thryv’s rapid pivot toward higher-margin SaaS and AI-powered tools, with SaaS revenue rising sharply, margins...
NasdaqGS:OPCH
NasdaqGS:OPCHHealthcare

Is OPCH’s Enlarged Buyback and Reaffirmed 2026 Outlook Reframing Its Capital Return Story?

Option Care Health, Inc. recently reported its fourth-quarter and full-year 2025 results, with Q4 sales rising to US$1,465.45 million while net income eased slightly to US$58.5 million, and full-year sales increasing to US$5.65 billion alongside modestly higher earnings per share from continuing operations. Alongside these results, the company reaffirmed its 2026 outlook and expanded its share repurchase authorization to US$1 billion, highlighting management’s focus on capital returns even...
NasdaqGS:FHB
NasdaqGS:FHBBanks

Is First Hawaiian (FHB) Using Segment Realignment And Buybacks To Quietly Redefine Its Core Strategy?

First Hawaiian, Inc. recently filed its 2025 10-K, detailing a shift to two core segments, Retail Banking and Commercial Banking, alongside US$129.9 million in dividends and US$100.0 million in share repurchases, reinforcing its current capital allocation priorities. The combination of segment realignment and sizeable capital returns highlights how management is repositioning the bank’s business mix while returning excess capital to shareholders. Next, we’ll examine how the new Retail and...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

Assessing Arrowhead Pharmaceuticals (ARWR) Valuation As Its RNAi Pipeline Advances To Phase 3 With Big Pharma Partners

Arrowhead Pharmaceuticals (ARWR) is back in focus as investors react to progress in its RNA interference drug pipeline, including two therapies in Phase 3 trials and multiple partnerships with large pharmaceutical partners. See our latest analysis for Arrowhead Pharmaceuticals. The recent excitement around Arrowhead’s RNAi pipeline and partnerships comes after a choppy few weeks for the stock, with a 1 month share price return of an 8.74% decline but a 90 day share price return of 12.48%...